Literature DB >> 4138585

Development of immunotherapy for infections due to Pseudomonas aeruginosa.

M W Fisher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4138585     DOI： 10.1093/infdis/130.supplement.s149

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Evaluation of a new polyvalent Pseudomonas vaccine in respiratory infections.

Authors:  J E Pennington; J J Miler
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

2.  Topical immunotherapy for pseudomonas keratitis in rabbits: use of antilipopolysaccharide plasma.

Authors:  N H Welsh; A J Rauch; S L Gaffin
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

3.  Polyvalent antisera to Pseudomonas ribosomal vaccines: protection of mice against clinically isolated strains.

Authors:  M M Lieberman; G L Wright; K M Wolcott; D C McKissock-Desoto
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

4.  Infections caused by Pseudomonas aeruginosa: relatively frequent isolation of serogroup 12 from clinical specimens.

Authors:  A Giammanco; R Di Stefano; S Arista; A Sinatra; A Chiarini
Journal:  Eur J Epidemiol       Date:  1985-06       Impact factor: 8.082
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.